These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35464007)

  • 1. Therapeutic Prospects of Polysaccharides for Ovarian Cancer.
    Wang K; Cai M; Sun S; Cheng W; Zhai D; Ni Z; Yu C
    Front Nutr; 2022; 9():879111. PubMed ID: 35464007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway.
    Bahar E; Kim JY; Kim DC; Kim HS; Yoon H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Genistein and its Derivatives in Ovarian Cancer: New Perspectives for Molecular Mechanisms and Clinical Applications.
    Chaichian S; Nikfar B; Bidgoli SA; Moazzami B
    Curr Med Chem; 2023 Oct; ():. PubMed ID: 37921172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis.
    Fontana F; Marzagalli M; Raimondi M; Zuco V; Zaffaroni N; Limonta P
    Cell Prolif; 2021 Nov; 54(11):e13111. PubMed ID: 34520051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer.
    Huang L; Zhang J; Deng Y; Wang H; Zhao P; Zhao G; Zeng W; Wang Y; Chen C; Wagstaff W; Haydon RC; Reid RR; He TC; Shen L; Luu HH; Zhao L
    Genes Dis; 2023 Jul; 10(4):1687-1701. PubMed ID: 37397523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells
    Yang H; Li H; Lu S; Shan S; Guo Y
    Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin-dependent kinase inhibitor AT7519 augments cisplatin's efficacy in ovarian cancer via multiple oncogenic signaling pathways.
    Wang L; Chen Y; Li H; Xu Q; Liu R
    Fundam Clin Pharmacol; 2022 Feb; 36(1):81-88. PubMed ID: 34212421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells.
    Moghbeli M
    J Ovarian Res; 2021 Sep; 14(1):127. PubMed ID: 34593006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.
    Zhang Y; Huang S; Guo Y; Li L
    Biomed Pharmacother; 2018 Oct; 106():1357-1363. PubMed ID: 30119207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.
    Li L; He D; Guo Q; Zhang Z; Ru D; Wang L; Gong K; Liu F; Duan Y; Li H
    J Nanobiotechnology; 2022 Jan; 20(1):50. PubMed ID: 35078498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway.
    Ma N; Zhao Y
    Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.
    Sun Q; Dong M; Wang Z; Wang C; Sheng D; Li Z; Huang D; Yuan C
    Oncotarget; 2016 May; 7(19):28369-83. PubMed ID: 27058760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant-Derived Chinese Medicine Monomers on Ovarian Cancer via the Wnt/
    Xu JY; Liu FY; Liu SX; Xie LZ; Li J; Ma YT; Han FJ
    J Oncol; 2021; 2021():6852867. PubMed ID: 34912456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of miR-1246 Induces Cell Cycle Arrest and Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells by Promoting ZNF23 Transcription.
    Cai L; Zhang Q; Du L; Zheng F
    Cytogenet Genome Res; 2021; 161(10-11):488-500. PubMed ID: 34923485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
    Yuan S; Xu Y; Yi T; Wang H
    J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Aurora A Kinase Inhibitor Fangchinoline Enhances Cisplatin-DNA Adducts and Cisplatin Therapeutic Efficacy in OVCAR-3 Ovarian Cancer Cells-Derived Xenograft Model.
    Winardi D; Chu PY; Chen GY; Wang K; Hsu WY; Hsieh CL; Chen YH; Wu YC; Yang JC
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape.
    Zou X; Zhao Y; Liang X; Wang H; Zhu Y; Shao Q
    Front Immunol; 2021; 12():641937. PubMed ID: 33868274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragalus polysaccharides inhibit ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway.
    Guo Y; Zhang Z; Wang Z; Liu G; Liu Y; Wang H
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32159214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
    Zheng AW; Chen YQ; Fang J; Zhang YL; Jia DD
    Biomed Pharmacother; 2017 May; 89():1172-1177. PubMed ID: 28320083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.